Back to search
Pheochromocytoma/Paraganglioma (PPGL)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pheochromocytoma/Paraganglioma (PPGL) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pheochromocytoma/Paraganglioma (PPGL) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic ne…
To investigate the impact of a medication called Belzutifan on the production and subsequent metabolism of adrenaline and noradrenaline collectively termed 'cat…
Background: Fibroblast-activation protein (FAP) is an enzyme that appears in high numbers in cancer-associated fibroblasts of certain cancer types. \[18F\]FAPI…
The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocyt…
To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ACC or PPGL.
This multicenter retrospective Italian study evaluates the efficacy and safety of PRRT in patients with advanced, unresectable or metastatic pheochromocytomas a…